Dynacure, a clinical stage drug development company supported by SATT Conectus at the beginning of the story, announced the close of a €50 million Series C financing led by Perceptive Advisors. New investors participating in this financing include Bpifrance Large Venture and funds managed by Tekla Capital Management LLC. Dynacure’s existing investors Andera Partners, Bpifrance […]